Advertisement
U.S. markets open in 3 hours 21 minutes
  • S&P Futures

    5,304.00
    -4.25 (-0.08%)
     
  • Dow Futures

    40,138.00
    -6.00 (-0.01%)
     
  • Nasdaq Futures

    18,480.25
    -23.50 (-0.13%)
     
  • Russell 2000 Futures

    2,135.50
    -2.90 (-0.14%)
     
  • Crude Oil

    81.95
    +0.60 (+0.74%)
     
  • Gold

    2,217.80
    +5.10 (+0.23%)
     
  • Silver

    24.57
    -0.18 (-0.74%)
     
  • EUR/USD

    1.0782
    -0.0048 (-0.44%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • Vix

    13.01
    +0.23 (+1.80%)
     
  • GBP/USD

    1.2603
    -0.0035 (-0.28%)
     
  • USD/JPY

    151.4460
    +0.2000 (+0.13%)
     
  • Bitcoin USD

    70,635.08
    +701.24 (+1.00%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,970.87
    +38.89 (+0.49%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Illumina beats on huge EPS rise

The maker of gene sequencing systems earned 87 cents a share in Q4, a 93% rise from last year that topped views by 9 cents. Revenue grew 32% to $512 mil, above estimates for $506 mil. Illumina (ILMN) says that its new HiSeq and NextSeq instruments "further enhance the most extensive sequencing portfolio available." Illumina expects '15 revenue growth of 20% and adjusted EPS of $3.12-$3.18. Analysts see 22% sales growth and EPS of $3.20. Shares rose 1.9% to 207 in after-hours trade.

Advertisement